These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26490041)

  • 1. Retrieval of Disseminated Tumor Cells Colonizing the Bone in Murine Breast Cancer Metastasis Models.
    Welte T; Yu C; Zhang XH
    J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):103-8. PubMed ID: 26490041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.
    Valkenburg KC; Amend SR; Verdone JE; van der Toom EE; Hernandez JR; Gorin MA; Pienta KJ
    Oncotarget; 2016 Oct; 7(43):69794-69803. PubMed ID: 27634877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
    Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
    BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.
    Shimizu H; Takeishi S; Nakatsumi H; Nakayama KI
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
    Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast Cancer Dormancy in Bone.
    Clements ME; Johnson RW
    Curr Osteoporos Rep; 2019 Oct; 17(5):353-361. PubMed ID: 31468498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
    Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
    Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model.
    Pillai SG; Li S; Siddappa CM; Ellis MJ; Watson MA; Aft R
    Breast Cancer Res; 2018 Jan; 20(1):2. PubMed ID: 29291741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood clot formation does not affect metastasis formation or tumor growth in a murine model of breast cancer.
    Rossnagl S; von Au A; Vasel M; Cecchini M; Nakchbandi IA
    PLoS One; 2014; 9(4):e94922. PubMed ID: 24740307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
    Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
    J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
    Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
    PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
    Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
    Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
    Krishnamurthy S; Cristofanilli M; Singh B; Reuben J; Gao H; Cohen EN; Andreopoulou E; Hall CS; Lodhi A; Jackson S; Lucci A
    Cancer; 2010 Jul; 116(14):3330-7. PubMed ID: 20564098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.
    Cawthorn TR; Amir E; Broom R; Freedman O; Gianfelice D; Barth D; Wang D; Holen I; Done SJ; Clemons M
    Clin Exp Metastasis; 2009; 26(8):935-43. PubMed ID: 19697143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
    Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
    Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer.
    Cackowski FC; Wang Y; Decker JT; Sifuentes C; Weindorf S; Jung Y; Wang Y; Decker AM; Yumoto K; Szerlip N; Buttitta L; Pienta KJ; Morgan TM; Taichman RS
    Prostate; 2019 Oct; 79(14):1715-1727. PubMed ID: 31449673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow.
    Buschhaus JM; Humphries BA; Eckley SS; Robison TH; Cutter AC; Rajendran S; Haley HR; Bevoor AS; Luker KE; Luker GD
    Oncogene; 2020 Aug; 39(34):5649-5662. PubMed ID: 32678295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.